Health
Italian COVID-19 vaccine shows strong immune response in mid-stage trial – bdnews24.com
Italy’s hopes of producing its own COVID-19 vaccine were given a boost on Monday when local biotech firm ReiThera said its vaccine…
The vaccine, called GRAd-COV2, induced an antibody response against the SARS-CoV-2 spike protein in over 93 percent of volunteers three weeks after the first dose, reaching 99 percent after the second dose, the company said in a statement.
However, ReiThera…
Continue Reading
-
Business22 hours agoWhat I’d buy if I had to invest $20,000 in ASX 200 shares before the weekend
-
General21 hours agoFederal government funding extends cohealth GP services until July 2026
-
Noosa News19 hours agoSunshine Coast Airport receives green light for major upgrade opening doors to growth jobs and tourism across the region
-
General5 hours agoMildura man given 28 years to pay $73,000 in unpaid fines and tolls